• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肺部疾病的干细胞疗法:从基础研究到临床应用

Stem cell therapy for lung diseases: From fundamental aspects to clinical applications.

作者信息

Hosseinirad Hossein, Rashidi Mohsen, Moghaddam Mehrdad Moosazadeh, Tebyanian Hamid, Nouraei Soheila, Mirhosseini Seyed Ali, Rasouli Mehdi, Habibian Soheil

机构信息

Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Faculty of Medicine, Mazandaran University of Medical Sciences Department of Physiology and Pharmacology, Sari Iran.

出版信息

Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):92-101.

PMID:30084809
Abstract

The respiratory system is a complex group of organs in the human body, all of which are necessary in breathing. Due to its special anatomy and composition, after exposure to various damaging factors such as micro particles, carbon granules and toxic gases, the respiratory system can be affected by a variety of damage without return to its original state. Currently, the prevalence of lung diseases, including asthma, and chronic obstructive pulmonary diseases, such as emphysema, has increased remarkably. New therapeutic approaches are desperately needed to discover regenerative medicine approaches, especially cell therapy. This review summarizes the recent advances in stem cell treatments and the research efforts conducted through the application of stem cell therapy for respiratory system diseases. In particular, researchers have used animal models to gather data about treating lung injury by stem cell transplantation. This review concentrated on the findings about route, timing and adjustment of cell transplantation dose, optimum stem cell type selection and potency marker of cells as therapeutic agents. These factors are essential subjects for approval and clinical transplantation. The current clinical trials aiming at treatment of lung diseases by stem cells are mentioned and discussed.

摘要

呼吸系统是人体中一组复杂的器官,所有这些器官在呼吸过程中都是必需的。由于其特殊的解剖结构和组成,在接触各种有害因素,如微粒、碳颗粒和有毒气体后,呼吸系统会受到各种损害且无法恢复到原始状态。目前,包括哮喘在内的肺部疾病以及诸如肺气肿等慢性阻塞性肺疾病的患病率显著增加。迫切需要新的治疗方法来探索再生医学方法,尤其是细胞疗法。本综述总结了干细胞治疗的最新进展以及通过应用干细胞疗法治疗呼吸系统疾病所开展的研究工作。特别是,研究人员利用动物模型收集有关通过干细胞移植治疗肺损伤的数据。本综述重点关注细胞移植的途径、时机和剂量调整、最佳干细胞类型选择以及作为治疗剂的细胞效能标志物等方面的研究结果。这些因素是获批和临床移植的关键主题。文中提及并讨论了目前旨在通过干细胞治疗肺部疾病的临床试验。

相似文献

1
Stem cell therapy for lung diseases: From fundamental aspects to clinical applications.用于肺部疾病的干细胞疗法:从基础研究到临床应用
Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):92-101.
2
Stem cells and cell therapy approaches in lung biology and diseases.肺生物学和疾病中的干细胞和细胞治疗方法。
Transl Res. 2010 Sep;156(3):188-205. doi: 10.1016/j.trsl.2010.06.007. Epub 2010 Jul 7.
3
Concise review: current status of stem cells and regenerative medicine in lung biology and diseases.简明综述:干细胞与再生医学在肺生物学及疾病中的现状
Stem Cells. 2014 Jan;32(1):16-25. doi: 10.1002/stem.1506.
4
Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023.2023 年肺部生物学和疾病中的干细胞、细胞疗法和生物工程
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L327-L340. doi: 10.1152/ajplung.00052.2024. Epub 2024 May 21.
5
From Stem Cell Biology to The Treatment of Lung Diseases.从干细胞生物学到肺部疾病的治疗。
Curr Stem Cell Res Ther. 2017;12(6):493-505. doi: 10.2174/1574888X12666170523155846.
6
Deriving respiratory cell types from stem cells.从干细胞中衍生出呼吸细胞类型。
Curr Stem Cell Res Ther. 2007 Sep;2(3):197-208. doi: 10.2174/157488807781696203.
7
Lung stem cells: do they exist?肺干细胞:它们存在吗?
Respirology. 2013 May;18(4):587-95. doi: 10.1111/resp.12073.
8
Stem cells in lung repair and regeneration: Current applications and future promise.肺修复和再生中的干细胞:当前应用和未来前景。
J Cell Physiol. 2018 Oct;233(10):6414-6424. doi: 10.1002/jcp.26414. Epub 2018 Apr 18.
9
Development of respiratory stem cells and progenitor cells.呼吸道干细胞和祖细胞的发育。
Stem Cells Dev. 2004 Dec;13(6):607-13. doi: 10.1089/scd.2004.13.607.
10
Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.将基础研究转化为安全有效的基于细胞的呼吸疾病治疗方法。
Ann Am Thorac Soc. 2019 Jun;16(6):657-668. doi: 10.1513/AnnalsATS.201812-890CME.

引用本文的文献

1
Elevated expression of NLRP3 promotes cigarette smoke-induced airway inflammation in chronic obstructive pulmonary disease.NLRP3表达升高促进慢性阻塞性肺疾病中香烟烟雾诱导的气道炎症。
Arch Med Sci. 2024 Apr 25;20(4):1281-1293. doi: 10.5114/aoms/176805. eCollection 2024.
2
Epithelial cells/progenitor cells in developing human lower respiratory tract: Characterization and transplantation to rat model of pulmonary injury.发育中的人类下呼吸道上皮细胞/祖细胞:特性及移植至大鼠肺损伤模型
Bioimpacts. 2023;13(6):505-520. doi: 10.34172/bi.2023.26456. Epub 2023 Jul 22.
3
Pulmonary fibrosis: Is stem cell therapy the way forward?
肺纤维化:干细胞疗法是前进的方向吗?
J Taibah Univ Med Sci. 2023 Oct 11;19(1):82-89. doi: 10.1016/j.jtumed.2023.09.009. eCollection 2024 Feb.
4
Comparing chronic obstructive pulmonary disease and depressive disorder in terms of inflammation-related biomarkers.从炎症相关生物标志物的角度比较慢性阻塞性肺疾病和抑郁症。
Arch Med Sci. 2023 May 24;19(3):814-819. doi: 10.5114/aoms/161803. eCollection 2023.